Avastin bevacizumab: Phase III started

Last quarter, Genentech began the Phase III OCEANS trial in 450 relapsed patients to evaluate carboplatin and gemcitabine plus either 15 mg/kg Avastin or placebo. Genentech markets Avastin in the U.S....